Literature DB >> 18430911

Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Jeanne M Madden1, Amy J Graves, Fang Zhang, Alyce S Adams, Becky A Briesacher, Dennis Ross-Degnan, Jerry H Gurwitz, Marsha Pierre-Jacques, Dana Gelb Safran, Gerald S Adler, Stephen B Soumerai.   

Abstract

CONTEXT: Cost-related medication nonadherence (CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage (Part D) on CRN is unknown.
OBJECTIVE: To estimate changes in CRN and forgoing basic needs to pay for drugs following Part D implementation. DESIGN, SETTING, AND PARTICIPANTS: In a population-level study design, changes in study outcomes between 2005 and 2006 before and after Medicare Part D implementation were compared with historical changes between 2004 and 2005. The community-dwelling sample of the nationally representative Medicare Current Beneficiary Survey (unweighted unique n = 24,234; response rate, 72.3%) was used, and logistic regression analyses were controlled for demographic characteristics, health status, and historical trends. MAIN OUTCOME MEASURES: Self-reports of CRN (skipping or reducing doses, not obtaining prescriptions) and spending less on basic needs to afford medicines.
RESULTS: The unadjusted, weighted prevalence of CRN was 15.2% in 2004, 14.1% in 2005, and 11.5% after Part D implementation in 2006. The prevalence of spending less on basic needs was 10.6% in 2004, 11.1% in 2005, and 7.6% in 2006. Adjusted analyses comparing 2006 with 2005 and controlling for historical changes (2005 vs 2004) demonstrated significant decreases in the odds of CRN (ratio of odds ratios [ORs], 0.85; 95% confidence interval [CI], 0.74-0.98; P = .03) and spending less on basic needs (ratio of ORs, 0.59; 95% CI, 0.48-0.72; P < .001). No significant changes in CRN were observed among beneficiaries with fair to poor health (ratio of ORs, 1.00; 95% CI, 0.82-1.21; P = .97), despite high baseline CRN prevalence for this group (22.2% in 2005) and significant decreases among beneficiaries with good to excellent health (ratio of ORs, 0.77; 95% CI, 0.63-0.95; P = .02). However, significant reductions in spending less on basic needs were observed in both groups (fair to poor health: ratio of ORs, 0.60; 95% CI, 0.47-0.75; P < .001; and good to excellent health: ratio of ORs, 0.57; 95% CI, 0.44-0.75; P < .001).
CONCLUSIONS: In this survey population, there was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation. However, no net decrease in CRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.

Entities:  

Mesh:

Year:  2008        PMID: 18430911      PMCID: PMC3781951          DOI: 10.1001/jama.299.16.1922

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  35 in total

1.  Prescription drug costs for Medicare beneficiaries: coverage and health status matter.

Authors:  B Stuart; D Shea; B Briesacher
Journal:  Issue Brief (Commonw Fund)       Date:  2000-01

2.  Prescription drug coverage and seniors: how well are states closing the gap?

Authors:  Dana Gelb Safran; Patricia Neuman; Cathy Schoen; Jana E Montgomery; Wenjun Li; Ira B Wilson; Michelle S Kitchman; Andrea E Bowen; William H Rogers
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Dec       Impact factor: 6.301

3.  Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.

Authors:  Mary A Laschober; Michelle Kitchman; Patricia Neuman; Allison A Strabic
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Dec       Impact factor: 6.301

4.  What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes.

Authors:  Anthony S Robbins; Susan Y Chao; Vincent P Fonseca
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

5.  Uncovering the health challenges facing people with disabilities: the role of health insurance.

Authors:  Kristina W Hanson; Patricia Neuman; David Dutwin; Judith D Kasper
Journal:  Health Aff (Millwood)       Date:  2003 Jul-Dec       Impact factor: 6.301

6.  Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.

Authors:  A D Federman; A S Adams; D Ross-Degnan; S B Soumerai; J Z Ayanian
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

Review 7.  Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living.

Authors:  S Katz
Journal:  J Am Geriatr Soc       Date:  1983-12       Impact factor: 5.562

8.  Benefits and risks of increasing restrictions on access to costly drugs in Medicaid.

Authors:  Stephen B Soumerai
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Feb       Impact factor: 6.301

9.  The health effects of restricting prescription medication use because of cost.

Authors:  Michele Heisler; Kenneth M Langa; Elizabeth L Eby; A Mark Fendrick; Mohammed U Kabeto; John D Piette
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

10.  Reporting of drug expenditures in the MCBS.

Authors:  John A Poisal
Journal:  Health Care Financ Rev       Date:  2003
View more
  104 in total

1.  Just because it's low cost doesn't mean it's accessible.

Authors:  Dima M Qato; G Caleb Alexander
Journal:  J Gen Intern Med       Date:  2012-10       Impact factor: 5.128

2.  Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.

Authors:  Becky A Briesacher; Dennis Ross-Degnan; Anita K Wagner; Hassan Fouayzi; Fang Zhang; Jerry H Gurwitz; Stephen B Soumerai
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

3.  Impact of generic substitution decision support on electronic prescribing behavior.

Authors:  Shane P Stenner; Qingxia Chen; Kevin B Johnson
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

4.  Food Insecurity and Cost-Related Medication Underuse Among Nonelderly Adults in a Nationally Representative Sample.

Authors:  Dena Herman; Patience Afulani; Alisha Coleman-Jensen; Gail G Harrison
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

5.  Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

Authors:  Jessica Williams; William N Steers; Susan L Ettner; Carol M Mangione; Obidiugwu K Duru
Journal:  Med Care       Date:  2013-02       Impact factor: 2.983

6.  Cost-related medication nonadherence in older patients with rheumatoid arthritis.

Authors:  Leslie R Harrold; Becky A Briesacher; Dan Peterson; Ashley Beard; Jeanne Madden; Fang Zhang; Jerry H Gurwitz; Stephen B Soumerai
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

7.  A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey.

Authors:  Hassan Fouayzi; Arlene S Ash; Amy K Rosen
Journal:  Health Serv Res       Date:  2020-04-14       Impact factor: 3.402

8.  Medicare Part D coverage gap and diabetes beneficiaries.

Authors:  Julie A Schmittdiel; Susan L Ettner; Vicki Fung; Jie Huang; Norman Turk; Elaine S Quiter; Bix E Swain; John T Hsu; Carol M Mangione
Journal:  Am J Manag Care       Date:  2009-03       Impact factor: 2.229

9.  Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Authors:  Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law
Journal:  CMAJ Open       Date:  2018-11-19

10.  Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Authors:  Vicki Fung; Carol M Mangione; Jie Huang; Norman Turk; Elaine S Quiter; Julie A Schmittdiel; John Hsu
Journal:  Health Serv Res       Date:  2009-12-30       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.